AI tools can empower regulatory professionals while also creating new challenges. Learn how to address accuracy, relevance, and comprehensiveness through practical examples—and apply AI operationally in your regulatory work.
Conversational large language models (LLMs) are helping regulatory teams find and interpret information, but their responses can fall short in accuracy, relevance, and comprehensiveness. The efficiency gained in searching for information comes with a critical need for review and validation. Through practical examples, this session examines the challenges regulatory professionals face when working with conversational LLMs and practical ways to address them. It then explores how AI can support regulation research, guideline comparisons, and precedent identification, before considering how to implement AI operationally in Regulatory Intelligence. Practical reflections on ways that AI assists in regulatory practice as well as opportunities where AI can improve to become a more useful tool to the regulatory professional will be part of the discussion.
Biodesix, Inc.
919 W Dillon Rd
Louisville, CO 80027
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].
Associate Principal Consultant, Regulatory CMC, Salamandra, LLC
Founder/CEO, Cedience
Amin Osmani is the founder/CEO at Cedience, the company building proactive AI agents for intelligence teams and the critical decisions they support.Associate Principal Consultant, Regulatory CMC, Salamandra, LLC
Shawn is an Associate Principal Consultant at Salamandra, LLC specializing in regulatory CMC strategy. He has been working in regulatory CMC consulting since 2012. He has worked with clients across the drug development spectrum from the very early concept stage and strategy to marketing application to post approval commercialization. He has worked on multiple different therapeutic modalities including small molecules, oligonucleotides, peptides, monoclonal antibodies, live biotherapeutic products and synthetic cannabinoids. He has led multiple regulatory filings across the development process and in multiple health authority jurisdictions. Prior to transitioning to Regulatory CMC, Shawn worked in the nucleic acid therapeutics development space in the Boulder, CO area after completing his post-doctoral fellowship on the Human Genome Project.